Madrigal Pharmaceuticals (MDGL) News Today $344.97 +33.83 (+10.87%) Closing price 04:00 PM EasternExtended Trading$342.38 -2.60 (-0.75%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MDGL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Madrigal stock jumps as patent protection for MASH treatment extended2 hours ago | in.investing.comMadrigal Pharmaceuticals shares surge after extended patent protection for MASH therapy2 hours ago | msn.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Up - Should You Buy?July 16 at 10:59 AM | marketbeat.comMadrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffraâ„¢ (Resmetirom)July 16 at 8:13 AM | globenewswire.comEmerald Advisers LLC Has $15.87 Million Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 13 at 6:09 AM | marketbeat.comEmerald Mutual Fund Advisers Trust Purchases 16,582 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 12, 2025 | marketbeat.comD.A. Davidson & CO. Acquires 1,458 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 10, 2025 | marketbeat.comCannon Global Investment Management LLC Makes New $497,000 Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 3, 2025 | marketbeat.comMadrigal Pharma (MDGL) Share News Today - Investing.com UKJuly 2, 2025 | uk.investing.comJMP Reaffirms Price Target for Madrigal Amid Rezdiffra Growth PotentialJuly 2, 2025 | msn.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 1, 2025 | marketbeat.comMadrigal, Viking among notable gainers after Altimmune’s MASH setbackJune 26, 2025 | msn.comMadrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, RezdiffraJune 24, 2025 | msn.comMadrigal Pharmaceuticals: GLP-1s Inch Closer To MASH Market As REZDIFFRA OutperformsJune 23, 2025 | seekingalpha.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Stock, Insider Trading ActivityJune 21, 2025 | benzinga.comEU regulator backs conditional authorisation for Madrigal's liver disease drugJune 20, 2025 | msn.comMadrigal Pharmaceuticals Gets CHMP Backing for Rezdiffra ApprovalJune 20, 2025 | marketwatch.comEU medicines regulator grants conditional authorisation for Madrigal's liver disease drugJune 20, 2025 | msn.comMadrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver FibrosisJune 20, 2025 | finance.yahoo.comMadrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver FibrosisJune 20, 2025 | globenewswire.comMadrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)June 19, 2025 | finanznachrichten.deMadrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)June 17, 2025 | globenewswire.comHandelsbanken Fonder AB Decreases Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)June 15, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Shares Up 6% - Should You Buy?June 11, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Acquired by Rhumbline AdvisersJune 11, 2025 | marketbeat.comCantor Fitzgerald Weighs in on MDGL FY2026 EarningsJune 10, 2025 | marketbeat.comRheos Capital Works Inc. Sells 13,000 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)June 9, 2025 | marketbeat.comGAMMA Investing LLC Has $12.95 Million Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)June 7, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesJune 6, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Has $3.65 Million Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)June 5, 2025 | marketbeat.comMadrigal Pharmaceuticals to Present at 46th Annual Goldman Sachs Health Care ConferenceJune 3, 2025 | msn.comMadrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care ConferenceJune 2, 2025 | globenewswire.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 1, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stake Lowered by Ameriprise Financial Inc.May 30, 2025 | marketbeat.comAltimmune: Upcoming MASH Data Could Be High Impact For Business Development ActivityMay 29, 2025 | seekingalpha.comCetera Investment Advisers Has $889,000 Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 26, 2025 | marketbeat.comMan Group plc Makes New Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 25, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stake Lowered by Nuveen Asset Management LLCMay 25, 2025 | marketbeat.comProShare Advisors LLC Boosts Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 23, 2025 | marketbeat.comWoodline Partners LP Raises Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 22, 2025 | marketbeat.comVestal Point Capital LP Raises Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 21, 2025 | marketbeat.comSoleus Capital Management L.P. Makes New $3.36 Million Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 21, 2025 | marketbeat.comTema Etfs LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 20, 2025 | marketbeat.comRafferty Asset Management LLC Lowers Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 19, 2025 | marketbeat.comBNP Paribas Financial Markets Sells 2,846 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 19, 2025 | marketbeat.comDeutsche Bank AG Sells 5,284 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 18, 2025 | marketbeat.comIn Search Of A Tailwind, Sailing The Doldrums With Madrigal PharmaceuticalsMay 17, 2025 | seekingalpha.comPolar Capital Holdings Plc Has $42.50 Million Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)May 17, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Position Increased by Ensign Peak Advisors IncMay 15, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Bought by Bank of America Corp DEMay 15, 2025 | marketbeat.com Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address MDGL Media Mentions By Week MDGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDGL News Sentiment▼1.800.97▲Average Medical News Sentiment MDGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDGL Articles This Week▼68▲MDGL Articles Average Week Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News Today Incyte News Today United Therapeutics News Today Neurocrine Biosciences News Today Exelixis News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Halozyme Therapeutics News Today Repligen News Today Ionis Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDGL) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDGL Stock Alerts